HNSPF
Price
$4.97
Change
-$0.03 (-0.60%)
Updated
Dec 15 closing price
Capitalization
28.51B
Intraday BUY SELL Signals
HTSUY
Price
$6.65
Change
-$0.15 (-2.21%)
Updated
Nov 12 closing price
Capitalization
1.98B
Intraday BUY SELL Signals
Interact to see
Advertisement

HNSPF vs HTSUY

Header iconHNSPF vs HTSUY Comparison
Open Charts HNSPF vs HTSUYBanner chart's image
Hansoh Pharmaceutical Group
Price$4.97
Change-$0.03 (-0.60%)
Volume$927
Capitalization28.51B
Hisamitsu Pharmaceutical
Price$6.65
Change-$0.15 (-2.21%)
Volume$300
Capitalization1.98B
HNSPF vs HTSUY Comparison Chart in %
HNSPF
Daily Signal:
Gain/Loss:
HTSUY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HNSPF vs. HTSUY commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HNSPF is a Hold and HTSUY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (HNSPF: $4.97 vs. HTSUY: $6.65)
Brand notoriety: HNSPF and HTSUY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HNSPF: 354% vs. HTSUY: 128%
Market capitalization -- HNSPF: $28.51B vs. HTSUY: $1.98B
HNSPF [@Pharmaceuticals: Generic] is valued at $28.51B. HTSUY’s [@Pharmaceuticals: Generic] market capitalization is $1.98B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HNSPF’s FA Score shows that 2 FA rating(s) are green whileHTSUY’s FA Score has 2 green FA rating(s).

  • HNSPF’s FA Score: 2 green, 3 red.
  • HTSUY’s FA Score: 2 green, 3 red.
According to our system of comparison, HNSPF is a better buy in the long-term than HTSUY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HNSPF’s TA Score shows that 2 TA indicator(s) are bullish while HTSUY’s TA Score has 2 bullish TA indicator(s).

  • HNSPF’s TA Score: 2 bullish, 2 bearish.
  • HTSUY’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, HTSUY is a better buy in the short-term than HNSPF.

Price Growth

HNSPF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while HTSUY (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.01%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +23.01%.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.01% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HNSPF($28.5B) has a higher market cap than HTSUY($1.98B). HNSPF has higher P/E ratio than HTSUY: HNSPF (43.71) vs HTSUY (15.42). HNSPF YTD gains are higher at: 133.218 vs. HTSUY (-6.140).
HNSPFHTSUYHNSPF / HTSUY
Capitalization28.5B1.98B1,442%
EBITDAN/A32.5B-
Gain YTD133.218-6.140-2,170%
P/E Ratio43.7115.42284%
RevenueN/A155B-
Total CashN/A113B-
Total DebtN/A2.38B-
TECHNICAL ANALYSIS
Technical Analysis
HNSPFHTSUY
RSI
ODDS (%)
Bullish Trend 3 days ago
50%
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
25%
Bullish Trend 3 days ago
29%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
31%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
29%
Bullish Trend 3 days ago
13%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
13%
Bullish Trend 3 days ago
14%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 6 days ago
37%
Bearish Trend 3 days ago
18%
View a ticker or compare two or three
Interact to see
Advertisement
HNSPF
Daily Signal:
Gain/Loss:
HTSUY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
YCS50.730.38
+0.76%
ProShares UltraShort Yen
LRGG29.890.09
+0.30%
Nomura Focused Large Growth ETF
OVL54.08-0.03
-0.05%
Overlay Shares Large Cap Equity ETF
VBK308.75-1.13
-0.36%
Vanguard Small-Cap Growth ETF
QQQJ37.50-0.14
-0.37%
Invesco NASDAQ Next Gen 100 ETF

HNSPF and

Correlation & Price change

A.I.dvisor tells us that HNSPF and RMTI have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HNSPF and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSPF
1D Price
Change %
HNSPF100%
N/A
RMTI - HNSPF
24%
Poorly correlated
+6.83%
AYURF - HNSPF
11%
Poorly correlated
N/A
AKAN - HNSPF
8%
Poorly correlated
-10.31%
IXHL - HNSPF
5%
Poorly correlated
-2.87%
BFRI - HNSPF
4%
Poorly correlated
+0.17%
More

HTSUY and

Correlation & Price change

A.I.dvisor tells us that HTSUY and TKNO have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HTSUY and TKNO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HTSUY
1D Price
Change %
HTSUY100%
N/A
TKNO - HTSUY
4%
Poorly correlated
-1.70%
BFRI - HTSUY
4%
Poorly correlated
+0.17%
ORXOY - HTSUY
0%
Poorly correlated
N/A
HNSPF - HTSUY
0%
Poorly correlated
N/A
SWGHF - HTSUY
-1%
Poorly correlated
N/A
More